Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TFF Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
TFF Pharmaceuticals

TFF Pharmaceuticals

Public

TFF Pharmaceuticals: Innovating lung disease treatments through advanced dry powder drug delivery.

HQ
Austin, TX, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

TFF Pharmaceuticals, founded with a mission to revolutionize drug delivery for lung diseases, leverages its proprietary Thin Film Freezing (TFF) technology to convert medicines into dry powders. This innovative approach enhances the efficacy, safety, and stability of drugs, specifically targeting respiratory conditions. The company focuses on developing and commercializing these advanced formulations to provide faster and more effective treatments for lung-related ailments.

Notable figures associated with TFF Pharmaceuticals include experts in biopharmaceuticals and respiratory medicine. The company has attracted significant investment from industry leaders, fostering rapid development and commercialization of its products. Key achievements include the successful creation of numerous dry powder formulations that have demonstrated improved delivery and outcomes in preclinical studies. TFF Pharmaceuticals continues to impact the biopharmaceutical landscape by offering groundbreaking solutions for lung disease treatment.

TFF Pharmaceuticals - Similar Companies

Respira Therapeutics logo

Respira Therapeutics

Transpire Bio logo

Transpire Bio

transpirebio.com

TBT Pharma logo

TBT Pharma

tbtpharma.com

Theron Pharmaceuticals logo

Theron Pharmaceuticals

Qnovia logo

Qnovia

qnovia.com

Avalyn Pharma logo

Avalyn Pharma

avalynpharma.com

Nob Hill Therapeutics logo

Nob Hill Therapeutics

Terns Pharmaceuticals logo

Terns Pharmaceuticals

ternspharma.com

Therabron Therapeutics logo

Therabron Therapeutics

therabron.com

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

Transport Pharmaceuticals logo

Transport Pharmaceuticals

NovaDel Pharma logo

NovaDel Pharma

Pulmatrix logo

Pulmatrix

pulmatrix.com

Novel Therapeutic Technologies logo

Novel Therapeutic Technologies

ntt-inc.com

Vitranu logo

Vitranu

vitranu.com

TFF Pharmaceuticals - Quick Facts

Who are TFF Pharmaceuticals' competitors?

Companies similar to TFF Pharmaceuticals include Respira Therapeutics, Transpire Bio, TBT Pharma and Theron Pharmaceuticals.

When was TFF Pharmaceuticals founded?

TFF Pharmaceuticals was founded in 2018.

Where is TFF Pharmaceuticals' headquarters located?

TFF Pharmaceuticals' headquarters is located in Austin, TX, US.

When was TFF Pharmaceuticals' last funding round?

TFF Pharmaceuticals' most recent funding round was for $5M (USD) in August 2023.

How much has TFF Pharmaceuticals raised to-date?

As of Aug 15, 2023, TFF Pharmaceuticals has raised a total of $66.9M (USD).

How many employees does TFF Pharmaceuticals have?

TFF Pharmaceuticals has 15 employees as of Feb 6, 2024.

TFF Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • AI
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Drug Delivery
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research